Researchers from Utrecht University, together with fellow researchers from Erasmus MC and biotech company Harbor BioMed, have developed a human antibody that can inhibit the new coronavirus (SARS-CoV-2).
Research leader and last author Berend-Jan Bosch (Utrecht University) does not want to raise false expectations. It is a promising first step, but it is far too early to speculate about the potential efficacy in humans. The research is being reviewed by a leading scientific journal. Further comments can be provided once the item has been accepted.